Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GOA
|
|||
| Former ID |
DNC004659
|
|||
| Drug Name |
OL-92
|
|||
| Synonyms |
OL-92; CHEMBL367966; 288862-84-0; SCHEMBL3964425; BDBM23316; KB-79673; 1-[1,3]oxazolo[4,5-b]pyridin-2-yl-7-phenylheptan-1-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H20N2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NC3=C(O2)C=CC=N3
|
|||
| InChI |
1S/C19H20N2O2/c22-16(19-21-18-17(23-19)13-8-14-20-18)12-7-2-1-4-9-15-10-5-3-6-11-15/h3,5-6,8,10-11,13-14H,1-2,4,7,9,12H2
|
|||
| InChIKey |
OVFUWDCWLWBDJD-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 288862-84-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors. J Med Chem. 2009 Jan 8;52(1):170-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.